How to legally get Wegovy online in Illinois

Introduction

The landscape of obesity treatment has been transformed by GLP-1 medications like Wegovy, Ozempic, and Mounjaro. As these treatments grow in popularity, many patients wonder: ‘Can I get a GLP-1 weight loss prescription through telehealth?’ The short answer is yes—these medications are legally available through telehealth in all 50 states, though specific requirements vary by location.

This comprehensive guide breaks down the telehealth regulations for GLP-1 weight loss medications across the United States as of December 2025. We’ll explore which states allow full telehealth prescribing, which require an initial in-person visit, and what you need to know about provider qualifications and patient eligibility.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Understanding GLP-1 Medications and Telehealth Basics

What Are GLP-1 Medications?

GLP-1 receptor agonists are medications that were initially developed for type 2 diabetes but have proven highly effective for weight management. The most popular options include:

• Wegovy (semaglutide 2.4mg): FDA-approved specifically for weight management
• Ozempic (semaglutide 0.5-1mg): Approved for diabetes, often prescribed off-label for weight loss
• Mounjaro/Zepbound (tirzepatide): Available in diabetes formulation (Mounjaro) and obesity-specific version (Zepbound)

These medications work by mimicking a hormone called GLP-1, which regulates appetite and insulin secretion.

Telehealth Regulatory Status

An important distinction for telehealth prescribing: GLP-1 medications are not controlled substances. This means they’re not subject to the strict DEA regulations (like the Ryan Haight Act) that govern medications like Adderall or opioids. At the federal level, there is no requirement for an in-person examination before prescribing GLP-1s via telehealth.

However, state laws can impose additional requirements, which is why understanding your state’s specific regulations is crucial.

State-by-State Telehealth Prescribing Guide

States With No In-Person Requirement

These states allow full telehealth prescribing of GLP-1 medications without requiring any in-person visits:

• California: Explicitly permits telehealth prescribing; NPs have independent practice authority after 3+ years
• Connecticut: Allows full telehealth prescribing but requires behavioral counseling alongside medication
• Florida: Permits telehealth prescribing but requires BMI ≥30 and follow-up visits at least every 3 months
• Illinois: Full telehealth prescribing allowed with no special weight-loss restrictions
• New York: Telehealth friendly state with no in-person requirement; NPs have independent practice after experience
• Pennsylvania: No in-person mandate, though NPs still require physician collaboration
• Washington: Pioneer telehealth state with no in-person requirements; NPs have full practice authority

States Requiring Initial In-Person Exam

These states typically require an initial face-to-face examination before allowing telehealth management:

• Arkansas: Must perform first examination in-person; among the most restrictive telehealth states
• Delaware: Requires an initial physical exam before tele-prescribing weight-loss medications
• Georgia: Requires in-person exam prior to telehealth weight management prescribing
• Mississippi: State law requires an initial in-person evaluation for weight management therapy
• New Jersey: Comprehensive in-person exam plus lab work required before telehealth management
• North Dakota: In-person initial exam expected per state medical board guidance
• South Carolina: Must examine patient in person first for weight management medications
• Texas: In-person exam generally expected prior to telehealth weight loss prescribing
• Utah: Initial in-person exam recommended though regulations are evolving
• Virginia: Must perform physical exam and labs initially before telehealth management

Who Can Prescribe GLP-1s via Telehealth?

Provider qualifications vary significantly by state:

States with Independent NP Practice

In these states, nurse practitioners can prescribe GLP-1 medications independently after meeting experience requirements:

• California (after 3+ years experience)
• Connecticut (after 3 years collaboration)
• Delaware (after 2 years collaboration)
• New York (after 3,600 practice hours)
• North Dakota (full practice state)
• Utah (full practice state as of 2023)
• Virginia (after 2 years experience)
• Washington (full practice state)

States Requiring Physician Oversight

In these states, NPs and PAs need some form of physician collaboration or supervision:

• Arkansas (APRN must have MD agreement)
• Florida (some NPs have limited independence)
• Georgia (MD protocol required)
• Illinois (written MD agreement required)
• Mississippi (MD collaboration required)
• New Jersey (joint protocol with physician)
• Pennsylvania (MD collaboration required)
• South Carolina (MD supervision with written protocol)
• Texas (MD delegation required; no independent practice)

At Klarity Health, we ensure all providers are appropriately licensed in your state and follow all applicable regulations.

Patient Eligibility for GLP-1 Weight Loss Medications

Despite their popularity, GLP-1s aren’t appropriate for everyone seeking weight loss. Clinical guidelines generally recommend these medications for:

• Patients with BMI ≥30 (obesity)
• Patients with BMI ≥27 with weight-related comorbidities (like hypertension, diabetes, sleep apnea)
• Patients who have attempted lifestyle modifications without success

Contraindications include:

• Personal or family history of medullary thyroid carcinoma or MEN2
• Pregnancy or planning pregnancy
• Active gallbladder disease
• History of pancreatitis
• Severe gastrointestinal disorders

Reputable telehealth providers (including Klarity Health) conduct thorough screenings to ensure these medications are prescribed only to appropriate candidates.

Common Misconceptions About Telehealth GLP-1 Prescriptions

Myth: ‘Anyone can get Ozempic online for quick weight loss’

Reality: Legitimate telehealth providers follow strict clinical guidelines. You’ll need to meet medical criteria (typically BMI ≥30 or BMI ≥27 with complications) and complete a comprehensive evaluation.

Myth: ‘These are just diet pills that can be prescribed casually’

Reality: GLP-1s are powerful medications that require monitoring. They’re not similar to older stimulant diet pills, and providers will set realistic expectations—gradual weight loss over months, not weeks.

Myth: ‘Telehealth means less medical oversight’

Reality: Proper telehealth care includes regular follow-ups, monitoring for side effects, and possibly lab work. At Klarity Health, our providers follow the same standard of care as in-person visits, with structured check-ins to track your progress.

Myth: ‘Compounded versions are just as good as brand-name’

Reality: The FDA banned most compounded semaglutide for weight loss in May 2025 due to safety concerns. Legitimate telehealth providers now only prescribe FDA-approved versions.

Red Flags When Seeking Telehealth GLP-1 Prescriptions

Be wary of telehealth services that:

• Guarantee a prescription without thorough evaluation
• Offer ‘compounded’ or overseas versions (now largely banned)
• Don’t schedule follow-up appointments
• Lack transparency about provider credentials
• Skip discussion of risks and alternatives
• Ask you to waive your rights or lack a physical address

Finding Safe, Legal Telehealth for Weight Loss

At Klarity Health, we prioritize patient safety and regulatory compliance while making weight management treatment accessible. Here’s what makes our approach different:

• Provider Availability: Quick appointments with licensed professionals in your state
• Transparent Pricing: Clear costs for consultations and ongoing care
• Insurance and Cash Options: We work with many major insurers and offer affordable cash pay options
• Comprehensive Care: Initial evaluation, personalized treatment plan, and regular follow-ups

What to Expect in Your Telehealth Journey

If you’re considering GLP-1 medications through telehealth, here’s a typical process:

1. Initial consultation: Complete a detailed health questionnaire and meet with a licensed provider via video
2. Evaluation: Your provider assesses your medical history, current health, weight, and previous weight loss attempts
3. Prescription decision: If appropriate, your provider will prescribe a GLP-1 medication
4. Pharmacy coordination: Your prescription is sent electronically to your preferred pharmacy
5. Follow-up care: Regular virtual check-

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid